Your browser doesn't support javascript.
loading
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.
Wu, Y Linda; van Hyfte, Grace; Özbek, Umut; Reincke, Marlene; Gampa, Anuhya; Mohamed, Yehia I; Nishida, Naoshi; Wietharn, Brooke; Amara, Suneetha; Lee, Pei-Chang; Scheiner, Bernhard; Balcar, Lorenz; Pinter, Matthias; Vogel, Arndt; Weinmann, Arndt; Saeed, Anwaar; Pillai, Anjana; Rimassa, Lorenza; Naqash, Abdul Rafeh; Muzaffar, Mahvish; Huang, Yi-Hsiang; Kaseb, Ahmed O; Kudo, Masatoshi; Pinato, David J; Ang, Celina.
Afiliación
  • Wu YL; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • van Hyfte G; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Özbek U; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Reincke M; Department of Medicine II, Faculty of Medicine, Medical Center University of Freiburg, Freiburg, Germany.
  • Gampa A; Section of Gastroenterology, Hepatology and Nutrition, The University of Chicago Medical Center, Chicago, IL, United States.
  • Mohamed YI; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Nishida N; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Wietharn B; Division of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Kansas City, KS, United States.
  • Amara S; Division of Hematology/Oncology, East Carolina University, Greenville, NC, United States.
  • Lee PC; Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan.
  • Scheiner B; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Balcar L; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Pinter M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Vogel A; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Weinmann A; Department of Internal Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Saeed A; Division of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Kansas City, KS, United States.
  • Pillai A; Section of Gastroenterology, Hepatology and Nutrition, The University of Chicago Medical Center, Chicago, IL, United States.
  • Rimassa L; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy.
  • Naqash AR; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Clinical and Research Hospital, Rozzano (Milan), Italy.
  • Muzaffar M; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.
  • Huang YH; Division of Hematology/Oncology, East Carolina University, Greenville, NC, United States.
  • Kaseb AO; Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan.
  • Kudo M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Pinato DJ; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Ang C; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital London, London, United Kingdom.
Front Oncol ; 13: 1128569, 2023.
Article en En | MEDLINE | ID: mdl-36865801
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos